All Episodes

Q2 2026 GPO Legislative Townhall

Best Practices for Bispecifics

Implementing Bispecifics in a Clinical Practice

Operationalizing Bispecifics in Practice

The Basics of Bispecifics

Q1 2026 GPO Legislative Townhall

Operationalizing Radiopharmaceuticals in Your Practice

Radiopharmaceuticals: Billing and Reimbursement

Radiopharmaceutical Landscape

Introduction to Radiopharmaceuticals

Q4 2025 GPO Legislative Townhall

Q3 GPO Legislative Townhall

Inflation Reduction Act: Current State

Q2 GPO Legislative Townhall

Inflation Reduction Act: Overview

505(b)(2) Operationalizing in Practice - Provider Perspective

505(b)(2) Operationalizing in Practice - Pharmacist Perspective

505(b)(2) Billing and Reimbursement

505(b)(2) Landscape and Pipeline

505(b)(2) Basics

Buy and Bill: Practice Perspective

Buy and Bill: The Basics

GPO 101: Legislative Townhall

Biosimilar Basics: Payer Perspective

Biosimilar Basics: Legislation

Biosimilar Basics: Market Landscape

Biosimilar Basics: Overview

GPO Legislative Townhall December 2023: Part 11

GPO Legislative Townhall December 2023: Part 10

GPO Legislative Townhall December 2023: Part 9

GPO Legislative Townhall August 2023: Part 8

GPO Legislative Townhall August 2023: Part 7

GPO Legislative Townhall May 2023: Part 6

GPO Legislative Townhall May 2023: Part 5

GPO Legislative Townhall May 2023: Part 4

GPO Legislative Townhall Feb 2023: Part 3

GPO Legislative Townhall Feb 2023: Part 2

GPO Legislative Townhall Feb 2023: Part 1

Operational Pathways for Biomarker Testing in NSCLC

Biosimilar Series: Part 5

Biosimilar Series: Part 4

Biosimilar Series: Part 3

Biosimilar Series: Part 2

Biosimilar Series: Part 1

Biomarkers: Emerging Targets and Technologies

Biomarker Testing: A Closer Look at When, Who, and How to Test

Germline Genetic Testing

Buy and Bill 101: Part 4

Buy and Bill 101: Part 3

Biomarkers 101: Basics of Biomarker Testing

Buy and Bill 101: Part 2

Buy and Bill 101: Part 1

Novel Agents and Toxicity Management 101

Using AI Clinical Decision Support to Manage Cancer Complexity

Paradigms, Policy and Pharmacogenomics: What community oncologists need to know

Clinical trials: How has precision medicine elevated the role of community oncology?

Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML

Off Our Chests: A Discussion with Dr. John and Liza Marshall

Precision Medicine Series: Evolution Part 2

Precision Medicine Series: Evolution Part 1

A Conversation with Annexus Health

Precision Medicine Series: Precision Medicine Center